Biotics Research Comments as FDA Addresses Fraudulent Claims

 In Products and Services
Rosenberg, Texas – May 3, 2017 – The FDA recently conducted an investigation of numerous websites searching for dietary supplement companies that are making cancer claims. The investigation resulted in the issuance of 14 Warning Letters. Following the Warning Letters, the FDA issued a Press Release prominently featuring pictures of products for which cancer claims had been made. One of the featured products in the Press Release, which was picked up by numerous media outlets, was Biotics Research’s Dysbiocide®.
 
It should be emphasized that Biotics Research Corporation did not receive a Warning Letter and has not been accused of making any inappropriate claims for its products, including Dysbiocide®.
 
The objectionable claims were not made by Biotics Research or any of its regional distributors but by a customer who allegedly made cancer claims for the product on its website. Of course making a claim for the cure, prevention, treatment, mitigation or diagnosis of cancer is clearly not allowed under the current law. Immediately upon learning of the dissemination of these inappropriate claims Biotics Research’s distributor terminated its relationship with the customer and has refused any further sales of Biotics Research’s products. If you have any questions regarding this matter contact Denis DeLuca (800-231-5777) at Biotics Research Corporation.
 
About Biotics Research Corporation
Biotics Research Corporation has been a leading manufacturer of specially designed nutritional supplements available through healthcare professionals for forty years. Our mission remains constant: to be the benchmark of excellence in nutritional science, technology and service, providing the clinician with reliable, innovative products of superior quality as well as the highest level of customer service. Visit www.BioticsResearch.com.
Recent Posts

Start typing and press Enter to search